Skip to main content
MITI
OTC Technology

Mitesco Adds $180K in Toxic Convertible Debt and Issues 1M Shares Amid Cash Crunch

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.026
Mkt Cap
$538.802K
52W Low
$0.023
52W High
$0.398
52W Position info
10% above low
Off High info
94% below high
Rel. Volume info
2.5× avg
Market data snapshot near publication time

MITI is trading near its 52-week low of $0.023 (10% above the low) on elevated volume (2.5× avg).

Summary

Mitesco raised $180,000 in new debt with steep discounts and issued 1 million shares for services, extending its runway but adding significant dilution risk.


Key Events · Financing and Capital Events · MITI

  • New Convertible Note from AJB

    AJB Capital Investments provided $20,000 in cash for a $22,000 note (10% OID) maturing February 2, 2027. Conversion is only available after a maturity payment default at 70% of the 5-day VWAP, with a 1.8 million share reserve.

  • High-Cost Term Notes

    C/M Capital Master Fund LP lent $100,000 and WVP lent $60,000, each with a 20% original issue discount and 60-day term. The notes require 100% of net proceeds from any future financing to be applied to repayment.

  • Share Issuance for Services

    The company agreed to issue 1,000,000 restricted common shares to a consulting group for software development, adding to the recent 17.1 million restricted share authorization.

  • Bridge Note Extensions

    Holders of $200,000 in 2025 Bridge Notes agreed to extend maturities: $78,000 to September 1, 2026 and the remainder to December 31, 2026.


Analysis · MITI · Technology

With only $8,000 in cash and $22.4M in current liabilities, Mitesco has taken on $180,000 in new high-cost debt and issued 1 million restricted shares for software development. The AJB note carries a 10% original issue discount and converts at a 30% discount to market only upon default, while the C/M and WVP notes carry a 20% OID and mandatory prepayment from any future financing. These terms are highly dilutive and reflect severe financing distress.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MITI was trading at $0.03 on OTC in the Technology sector, with a market capitalization of approximately $538.8K. The 52-week trading range was $0.02 to $0.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MITI - Latest Insights

MITI
Aug 17, 2026, 4:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0263
Real-time Price: $0.06584 info
Change: +$0.03954 (+150%) info
Market Cap: $3.186M info
MITI
Aug 10, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0343
Real-time Price: $0.06584 info
Change: +$0.03154 (+92%) info
Market Cap: $3.186M info
MITI
Aug 04, 2026, 7:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.035
Real-time Price: $0.06584 info
Change: +$0.03084 (+88%) info
Market Cap: $3.186M info
MITI
Jul 21, 2026, 5:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0975
Real-time Price: $0.06584 info
Change: -$0.03166 (-32%) info
Market Cap: $3.186M info
MITI
Jul 09, 2026, 4:13 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.06584 info
Change: -$0.00416 (-6%) info
Market Cap: $3.186M info